citrulline has been researched along with Parkinson Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nehru, B; Thakur, P | 1 |
Nicholas, AP | 1 |
Bergmans, PL; Kuiper, MA; Scheltens, P; Teerlink, T; Visser, JJ; Wolters, EC | 1 |
3 other study(ies) available for citrulline and Parkinson Disease
Article | Year |
---|---|
Inhibition of neuroinflammation and mitochondrial dysfunctions by carbenoxolone in the rotenone model of Parkinson's disease.
Topics: Animals; Antioxidants; Astrocytes; Carbenoxolone; Citrulline; Cytokines; Disease Models, Animal; Electron Transport; Enzyme Activation; Glial Fibrillary Acidic Protein; Glutathione; Inflammation; Inflammation Mediators; Male; Mesencephalon; Mitochondria; Nervous System; Nitric Oxide; Nitric Oxide Synthase Type II; Parkinson Disease; Rats, Sprague-Dawley; Rotenone | 2015 |
Dual immunofluorescence study of citrullinated proteins in Parkinson diseased substantia nigra.
Topics: Aged; Aged, 80 and over; Astrocytes; Case-Control Studies; Citrulline; Dopamine; Fluorescent Antibody Technique; Glial Fibrillary Acidic Protein; Humans; Male; Nerve Tissue Proteins; Neurons; Parkinson Disease; Protein Processing, Post-Translational; Substantia Nigra; Tyrosine 3-Monooxygenase | 2011 |
L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients.
Topics: Aged; Alzheimer Disease; Arginine; Citrulline; Glutamic Acid; Humans; Middle Aged; Multiple System Atrophy; Neurons; Nitric Oxide; Nitric Oxide Synthase; Parkinson Disease | 2000 |